Pine River Capital Management’s Pfizer PFE Stock Holding History

Pine River Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22,909	Closed	-$736K	–	438
2016 Q3	$736K	Sell	22,909 -8,748	-28%	-$293K	0.01%	319
2016 Q2	$1.06K	Sell	31,657 -105	-0.3%	-$3.35K	﹤0.01%	280
2016 Q1	$893K	Buy	31,762 +1,974	+7%	+$56.4K	0.01%	481
2015 Q4	$912K	Sell	29,788 -32,990	-53%	-$1.04M	0.01%	415
2015 Q3	$1.87M	Sell	62,778 -3,201	-5%	-$103K	0.02%	273
2015 Q2	$2.1M	Buy	65,979 +49,201	+293%	+$1.6M	0.02%	296
2015 Q1	$554K	Sell	16,778 -2,110,917	-99%	-$67.1M	0.01%	472
2014 Q4	$62.9M	Sell	2,127,695 -866,582	-29%	-$24.8M	0.8%	31
2014 Q3	$84M	Buy	2,994,277 +1,301,418	+77%	+$36.5M	0.98%	15
2014 Q2	$47.7M	Buy	+1,692,859	New	+$48.3M	0.73%	21
2013 Q4	–	Sell	-32,367	Closed	-$942K	–	681
2013 Q3	$882K	Sell	32,367 -2,636,085	-99%	-$71.7M	0.01%	417
2013 Q2	$70.9M	Buy	+2,668,452	New	+$73.7M	1.04%	11

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pine River Capital Management's PFE Position: Q4 2016 in Review

Pine River Capital Management sold out of Pfizer (PFE) in Q4 2016, closing a stake of 22,909 shares — an estimated $736K sold.

Pine River Capital Management first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $84M in Q3 2014. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Pine River Capital Management reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
Pine River Capital Management sold 22,909 Pfizer shares in Q4 2016, an estimated $736K.
Pine River Capital Management first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
Pine River Capital Management's Pfizer position peaked at $84M in Q3 2014.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.